GRANBY, QC, Sept. 26, 2012 /CNW Telbec/ - In keeping with its commitment
to foster industrial innovation in Québec, the Fonds de solidarité FTQ,
through Fonds de solidarité FTQ Investissements technologiques (FSIT),
today announced a $333,333 investment in Cadens Imaging, a rapidly
growing company that develops, manufactures and markets
computer-assisted medical imaging solutions to enhance diagnostic
confidence. Gestion Allard et Dubé, a private investment firm and
FSIT's partner, will invest $166,667.
Created earlier this year by the Fonds de solidarité FTQ, FSIT is a
partnership which has adopted a new approach of co-investing dedicated
to financing the industrial innovations of Québec technology firms at
the marketing or growth stage.
Founded in 2007, Granby-based Cadens Imaging has developed an innovative
technology, protected by strong patents. Its core product, Cadens
Colon, supports non-invasive colorectal cancer screening with a CT
scanner, facilitating detection and diagnosis. The software is already
used in Canada, Europe and Asia, and several distribution agreements
are under negotiation.
"Now that we've launched our first clinical virtual colonoscopy
application, which has been favourably received by radiologists, we are
looking for ways to diversify our platform across other clinical
applications and continue to invest in R&D in order to hold onto our
technological edge," said Florent Chandelier, co-founder and
vice-president of R&D and regulatory affairs at Cadens Imaging.
"Cadens Imaging, which has carved itself a place in a highly competitive
market with its innovative products, is just the kind of company FSIT
is looking to back," said Alain Denis, Senior Vice-President, New
Economy at the Fonds de solidarité FTQ and president of FSIT. "This new
round of financing will allow the company to continue its marketing
efforts and build a distribution network on its target markets."
"The strategy employed by Cadens Imaging will ensure revenue growth and
allow the company to establish the credibility of its products and
technology," remarked Alain Allard of Gestion Allard et Dubé. "Given
that health establishments are avidly seeking a cost-effective and
accurate screening solution, this company's product is extremely
"No one else has this kind of technology, which gives us a big
competitive edge," acknowledged Jean-Pierre Robert, President and CEO
Cadens Imaging. "Cadens Colon cuts the preparation time before the
clinical exam, optimizes the use of contrast agents to reduce incorrect
readings due to improper patient preparation, and when used as a second
reader, speeds up review time to support the final diagnosis. All these
advantages are appreciated by both the medical community and patients."
About the Fonds de solidarité FTQ
The Fonds de solidarité FTQ helps drive our economy. With net assets of
$8.5 billion as of May 31, 2012, the Fonds is a development capital
investment fund that channels the savings of Quebecers into investments
in all sectors of the economy to help further Québec's economic growth.
Its investments, in all sectors of the economy, contribute to the
creation and maintenance of businesses and development in Quebec. The
Fonds is a partner, either directly or through its network members, in
2,239 companies. With its 594,287 owner-shareholders, it has helped, on
its own or with other financial partners, to create, maintain and
protect 168,577 jobs. For more information, visit www.FondsFTQ.com.
SOURCE: FONDS DE SOLIDARITE FTQ
For further information:
Information for journalists only:
Senior Advisor, Press Relations and Communications
Fonds de solidarité FTQ
The Fonds' social media accounts: